Healthy Kids I-PAL
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03297541|
Recruitment Status : Completed
First Posted : September 29, 2017
Last Update Posted : May 16, 2018
|Condition or disease||Intervention/treatment||Phase|
|Childhood Obesity||Behavioral: m-health approach||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||10 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Healthy Kids at I-PAL (Interactive Physical Activity Lab)|
|Actual Study Start Date :||September 5, 2017|
|Actual Primary Completion Date :||December 12, 2017|
|Actual Study Completion Date :||December 12, 2017|
Experimental: m-health approach
All dyads will receive the m-health approach.
Behavioral: m-health approach
Parent/child dyads attend remote counseling sessions delivered over Internet-connected device (e.g. smartphone, iPad/tablet, laptop, or desktop computer). A counselor will deliver the lesson, review progress based on the objectively measured data, and provide individualized advice and problem-solving strategies for parent and child. Families will receive weekly contact via smartphone. Each lesson will include an interactive component for parent and child related to healthy eating and active play, as well as an interactive parenting training component. Lessons are based on the family treatment methods that effectively promote child and parent weight loss that is sustained for 10 years (Epstein et al., 1990; Epstein et al., 1981).
- Acceptability/feasibility of the mHealth approach [ Time Frame: Week 0 to Week 14-16 ]Acceptability/feasibility of the mHealth approach will be evaluated by a survey.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03297541
|United States, Louisiana|
|Southeastern Louisiana University|
|Hammond, Louisiana, United States, 70402|
|Principal Investigator:||Amanda Staiano, PhD||Pennington Biomedical Research Center|
|Principal Investigator:||Corby Martin, PhD||Pennington Biomedical Research Center|